
Company valuation, historical trends, and peer comparisons.
According to Jade Biosciences, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 769.46M. This represents a change of 3.53% compared to the average of 743.19M of the last 4 quarters.
The mean historical Enterprise Value of Jade Biosciences, Inc. over the last ten years is 415.71M. The current 769.46M Enterprise Value has changed 85.10% with respect to the historical average. Over the past ten years (40 quarters), JBIO's Enterprise Value was at its highest in in the June 2026 quarter at 1.25B. The Enterprise Value was at its lowest in in the June 2024 quarter at 18.50M.
Average
415.71M
Median
474.44M
Minimum
42.41M
Maximum
695.72M
Discovering the peaks and valleys of Jade Biosciences, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 834.17%
Maximum Annual Enterprise Value = 695.72M
Minimum Annual Increase = -92.60%
Minimum Annual Enterprise Value = 42.41M
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 396.17M | 834.17% |
| 2024 | 42.41M | -92.60% |
| 2023 | 573.07M | -17.63% |
| 2022 | 695.72M | 197.10% |
| 2021 | 234.18M | -57.63% |
The current Enterprise Value of Jade Biosciences, Inc. (JBIO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
337.22M
5-year avg
388.31M
10-year avg
415.71M
Jade Biosciences, Inc.’s Enterprise Value is less than First Tracks Biotherapeutics Inc (1.71B), greater than MoonLake Immunotherapeutics (595.44M), less than Vera Therapeutics, Inc. (2.32B), greater than Aclaris Therapeutics, Inc. (551.23M), greater than Kyverna Therapeutics, Inc. (324.63M), greater than Eledon Pharmaceuticals, Inc. (204.94M), greater than Contineum Therapeutics, Inc. (300.03M), greater than Dogwood Therapeutics, Inc. (32.33M), greater than Revelation Biosciences, Inc. (-8489402.00),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 1.71B | $1.87B | |
| 595.44M | $971.82M | |
| 2.32B | $2.29B | |
| 551.23M | $570.40M | |
| 324.63M | $323.44M | |
| 204.94M | $211.28M | |
| 300.03M | $308.16M | |
| 32.33M | $41.81M | |
| -8489402.00 | $2.25M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Jade Biosciences, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Jade Biosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Jade Biosciences, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Jade Biosciences, Inc. (JBIO)?
What is the 3-year average Enterprise Value for Jade Biosciences, Inc. (JBIO)?
What is the 5-year average Enterprise Value for Jade Biosciences, Inc. (JBIO)?
How does the current Enterprise Value for Jade Biosciences, Inc. (JBIO) compare to its historical average?